In 2018, the global ophthalmic lasers market was valued at USD 479.0 million and is projected to reach USD 989.9 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.3% over the forecast period from 2018 to 2032. North America led the market in 2018, accounting for a 29.08% share.
According to the World Health Organization (WHO), approximately 2.2 billion people worldwide experienced vision impairment in 2019. Leading causes of vision loss include diabetic retinopathy, cataracts, and glaucoma. The growing demand for medical lasers spans multiple applications, including aesthetics, dentistry, veterinary medicine, and surgical procedures. Among these, ophthalmic lasers held the largest market share in surgical applications in 2018. The significant unmet need for advanced treatment options for ocular diseases, along with efforts to reduce the global economic burden of vision impairment, has been a key driver in the development and adoption of ophthalmic laser technologies.
Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/ophthalmic-lasers-market-100952
Market Trends:
The ophthalmic lasers market is witnessing rapid advancements, primarily driven by the increasing adoption of laser-based treatments for various eye conditions. The growing demand for minimally invasive procedures has boosted the use of ophthalmic lasers in surgeries such as LASIK and cataract removal. Technological innovations, including AI-assisted laser systems, are further enhancing treatment precision and patient outcomes. Additionally, rising awareness about eye health and increasing healthcare investments are supporting the market’s expansion.
List of Companies Profiled:
· IRIDEX Corporation
· Lumenis
· NIDEK CO., LTD.
· Carl Ziess Meditec AG
· Ellex Medical Lasers Ltd.
· TOPCON CORPORATION
· NoIR Laser Company, LLC
· Lumibird
· Other players
Market Segmentation:
The ophthalmic lasers market is segmented based on product type, application, end-user, and region.
Product Type: The market includes excimer lasers, femtosecond lasers, Nd:YAG lasers, diode lasers, and others. Excimer lasers are commonly used for refractive error corrections, while femtosecond lasers provide high precision in cataract and corneal surgeries. Nd:YAG lasers are widely utilized in treating secondary cataracts and glaucoma. The growing preference for these advanced technologies has significantly contributed to the expansion of the ophthalmic lasers market.
Application: Ophthalmic lasers are used for various applications, including cataract removal, glaucoma treatment, refractive error corrections, diabetic retinopathy, and age-related macular degeneration (AMD). The cataract removal segment holds a substantial share of the ophthalmic lasers market, owing to the high prevalence of cataracts worldwide. Refractive error corrections, such as LASIK and PRK, are also gaining popularity, further driving market growth. The increasing number of diabetic patients suffering from retinopathy is another factor boosting the demand for laser treatments.
End-User: The ophthalmic lasers market serves hospitals, ophthalmic clinics, and ambulatory surgical centers. Hospitals hold a significant share due to their comprehensive facilities and ability to perform complex laser-based eye procedures. However, ophthalmic clinics are projected to experience the fastest growth in the ophthalmic lasers market as they offer specialized treatments with shorter patient waiting times. Ambulatory surgical centers are also gaining traction, particularly in developed regions, due to their cost-effective and efficient laser treatment services.
Market Growth:
The ophthalmic lasers market is expected to grow steadily over the coming years, fueled by the rising prevalence of eye disorders such as cataracts, glaucoma, and diabetic retinopathy. A growing geriatric population, which is more prone to vision-related issues, is also a key driver. Continuous advancements in laser technology are making procedures safer and more effective, further propelling market demand. Increasing healthcare expenditure and the expansion of ophthalmic care facilities worldwide contribute to the market’s positive growth trajectory.
Restraining Factors:
Despite its strong growth potential, the ophthalmic lasers market faces certain challenges. High costs associated with advanced laser systems and procedures limit accessibility, especially in developing regions. Additionally, a shortage of trained professionals to operate specialized ophthalmic laser equipment poses a barrier to widespread adoption. Regulatory constraints and the time-consuming approval process for new laser technologies further hinder market growth. Moreover, concerns related to post-procedure complications and the need for periodic maintenance of laser devices add to the challenges.
Regional Analysis:
The ophthalmic lasers market varies across different regions. North America dominates due to its advanced healthcare infrastructure, high adoption of innovative laser treatments, and rising cases of vision disorders. Europe is experiencing steady growth, driven by increased healthcare investments and an aging population. The Asia-Pacific region is expected to witness the fastest expansion in the ophthalmic lasers market, fueled by improving medical infrastructure, a large patient population, and rising healthcare expenditure. Meanwhile, Latin America, the Middle East, and Africa are emerging markets where growing awareness and government initiatives are boosting the adoption of ophthalmic laser treatments.
Key Industry Developments:
In March 2021, Lumenis Ltd., a global leader in energy-based medical devices for aesthetic and ophthalmic applications, announced a partnership with the AdventHealth Nicholson Center. This collaboration aims to establish a center of excellence through a medical training program, providing physicians with large-scale education in a safe environment during the pandemic.
Also in March 2021, Iridex Corporation, a leading provider of innovative ophthalmic laser-based medical products, entered into a strategic collaboration with Topcon Corporation. This partnership enhances Iridex’s product portfolio by leveraging Topcon’s extensive distribution network in the Asia-Pacific region and beyond, integrating Topcon’s diagnostic and treatment solutions for glaucoma and retina patients.